Health Cana­da is­sues two re­calls for Pfiz­er blood pres­sure drugs over im­pu­ri­ty

Last year, Pfiz­er stopped dis­tri­b­u­tion of megablock­buster smok­ing ces­sa­tion drug Chan­tix over an in­creased lev­el of car­cino­genic ni­trosamines.

Now, two of the Big Phar­ma’s blood pres­sure drugs have been re­called in Cana­da this week af­ter Cana­da’s health au­thor­i­ty found lev­els of a type of ni­trosamine too high to be al­lowed in the drugs.

Pfiz­er Cana­da re­called all 8 lots of blood pres­sure drug Ac­curet­ic yes­ter­day af­ter high­er-than-ap­proved lev­els of N-ni­troso-quinapril were found. That re­call was just two days af­ter the phar­ma sub­sidiary re­called 15 lots of In­der­al-LA, an­oth­er blood pres­sure drug, over sim­i­lar con­cerns over ni­trosamines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER